Evolutionary Traits of Toxins

[1]  R. Zwanzig,et al.  Levinthal's paradox. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Philip K. Russell,et al.  Botulinum toxin as a biological weapon: medical and public health management. , 2001, JAMA.

[3]  Alexey G. Murzin,et al.  β-Trefoil fold: Patterns of structure and sequence in the Kunitz inhibitors interleukins-1β and 1α and fibroblast growth factors , 1992 .

[4]  Jane R. Allison,et al.  Current computer modeling cannot explain why two highly similar sequences fold into different structures. , 2011, Biochemistry.

[5]  G. Schiavo,et al.  Neurotoxins affecting neuroexocytosis. , 2000, Physiological reviews.

[6]  K M Hahn,et al.  Differential expression of SNAP-25 protein isoforms during divergent vesicle fusion events of neural development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  John Orban,et al.  NMR structures of two designed proteins with high sequence identity but different fold and function , 2008, Proceedings of the National Academy of Sciences.

[8]  A. Zhmurov,et al.  Botulinum neurotoxin: unique folding of enzyme domain of the most-poisonous poison , 2014, Journal of biomolecular structure & dynamics.

[9]  Bal Ram Singh,et al.  Intimate details of the most poisonous poison , 2000, Nature Structural Biology.

[10]  Emile Zuckerkandl,et al.  The appearance of new structures and functions in proteins during evolution , 1975, Journal of Molecular Evolution.

[11]  Mauricio Montal,et al.  Botulinum neurotoxin: a marvel of protein design. , 2010, Annual review of biochemistry.

[12]  Roshan Kukreja,et al.  Biologically Active Novel Conformational State of Botulinum, the Most Poisonous Poison* , 2005, Journal of Biological Chemistry.

[13]  B. L. de Groot,et al.  Alternative splicing of SNAP-25 regulates secretion through nonconservative substitutions in the SNARE domain. , 2005, Molecular biology of the cell.

[14]  Howard Ochman,et al.  Pathogenicity Islands: Bacterial Evolution in Quantum Leaps , 1996, Cell.

[15]  C. Levinthal.  Are there pathways for protein folding , 1968 .

[16]  A. T. Carter,et al.  Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes. , 2007, Genome research.

[17]  M. Collins,et al.  Conserved structure of genes encoding components of botulinum neurotoxin complex M and the sequence of the gene coding for the nontoxic component in nonproteolyticClostridium botulinum type F , 1994, Current Microbiology.

[18]  Mark C. Field,et al.  Evolution of the eukaryotic membrane-trafficking system: origin, tempo and mode , 2007, Journal of Cell Science.

[19]  Li Li,et al.  Structure-Function Relationship of Clostridial Neurotoxins , 1999 .

[20]  M. Collins,et al.  Genetic Characterization of Clostridium botulinum Type A Containing Silent Type B Neurotoxin Gene Sequences (*) , 1996, The Journal of Biological Chemistry.

[21]  Leonard A. Smith,et al.  Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains , 2009, BMC Biology.

[22]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[23]  D. Boger,et al.  An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists , 2007, Proceedings of the National Academy of Sciences.

[24]  J. Barbieri,et al.  General aspects and recent advances on bacterial protein toxins. , 2013, Cold Spring Harbor perspectives in medicine.

[25]  Charles W Carter,et al.  Aminoacylating Urzymes Challenge the RNA World Hypothesis*♦ , 2013, The Journal of Biological Chemistry.

[26]  L. Longo,et al.  Protein design at the interface of the pre-biotic and biotic worlds. , 2012, Archives of biochemistry and biophysics.

[27]  R. Stevens,et al.  Crystal structure of botulinum neurotoxin type A and implications for toxicity , 1998, Nature Structural Biology.

[28]  N. Grishin.  Fold change in evolution of protein structures. , 2001, Journal of structural biology.

[29]  G. Ast,et al.  Alternative splicing: current perspectives , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.

[30]  M. Collins,et al.  Nucleotide Sequence of the Gene Coding for Proteolytic (Group I) Clostridium botulinum Type F Neurotoxin: Genealogical Comparison with other Clostridial Neurotoxins , 1995 .

[31]  H. Kumon,et al.  Molecular characterization of two forms of nontoxic‐nonhemagglutinin components of Clostridium botulinum type A progenitor toxins , 1995, FEBS letters.

[32]  T. Henkin.  Control of transcription termination in prokaryotes. , 1996, Annual review of genetics.

[33]  N. Fairweather,et al.  The complete nucleotide sequence of tetanus toxin. , 1986, Nucleic acids research.

[34]  R. Stevens,et al.  Sequence homology and structural analysis of the clostridial neurotoxins. , 1999, Journal of molecular biology.

[35]  Desmond G. Higgins,et al.  Fast and sensitive multiple sequence alignments on a microcomputer , 1989, Comput. Appl. Biosci..

[36]  H. Sarkar,et al.  Differential roles of developmentally distinct SNAP-25 isoforms in the neurotransmitter release process. , 2001, Biochemistry.

[37]  B. McConkey,et al.  Insights into the evolutionary origins of clostridial neurotoxins from analysis of the Clostridium botulinum strain A neurotoxin gene cluster , 2008, BMC Evolutionary Biology.

[38]  John Orban,et al.  The design and characterization of two proteins with 88% sequence identity but different structure and function , 2007, Proceedings of the National Academy of Sciences.

[39]  Andrew A. Peden,et al.  A genomic perspective on membrane compartment organization , 2001, Nature.

[40]  J. E. Villafranca,et al.  Ricin B chain is a product of gene duplication. , 1981, The Journal of biological chemistry.

[41]  Axel T Brunger,et al.  Botulinum Neurotoxin Heavy Chain Belt as an Intramolecular Chaperone for the Light Chain , 2007, PLoS pathogens.

[42]  S. Munro,et al.  An elaborate classification of SNARE proteins sheds light on the conservation of the eukaryotic endomembrane system. , 2007, Molecular biology of the cell.

[43]  Eric A. Johnson,et al.  Receptor binding enables botulinum neurotoxin B to sense low pH for translocation channel assembly. , 2011, Cell host & microbe.

[44]  L. Orgel,et al.  Template switching between PNA and RNA oligonucleotides , 1995, Nature.

[45]  C. Shoemaker,et al.  Botulinum Neurotoxin Is Shielded by NTNHA in an Interlocked Complex , 2012, Science.

[46]  B R Singh,et al.  Role of the disulfide cleavage induced molten globule state of type a botulinum neurotoxin in its endopeptidase activity. , 2001, Biochemistry.

[47]  S. Nauenburg,et al.  Proteolysis of SNAP‐25 Isoforms by Botulinum Neurotoxin Types A, C, and E , 1999, Journal of neurochemistry.

[48]  Tony Hunter,et al.  Microarray and cDNA sequence analysis of transcription during nerve-dependent limb regeneration , 2009, BMC Biology.

[49]  Yu Zhou,et al.  Anti-apoptotic activity of hemagglutinin-33 and botulinum neurotoxin and its implications to therapeutic and countermeasure issues. , 2012, Biochemical and biophysical research communications.

[50]  Liam M Longo,et al.  Simplified protein design biased for prebiotic amino acids yields a foldable, halophilic protein , 2013, Proceedings of the National Academy of Sciences.